Department of Gastroenterology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Department of Endoscope Center, Jiangmen Central Hospital, Jiangmen, Guangdong, China.
Medicine (Baltimore). 2022 Dec 30;101(52):e32501. doi: 10.1097/MD.0000000000032501.
Anemia was a risk factor for a worse prognosis of many diseases. This study aims to investigate the relationship between anemia and the severity and prognosis of acute pancreatitis (AP). Inpatients hospitalized at the First Affiliated Hospital of Guangdong Pharmaceutical University with a primary diagnosis of AP between 1st July 2016 to 31st December 2020 were enrolled. Subsequently, disease severity, the incidence of complications, and the prognosis of patients with AP were compared between the anemic group and the non-anemic group. A total of 282 patients with acute pancreatitis were enrolled; 68.43% of them were also diagnosed with anemia. Notably, these patients had more severe disease (higher RANSON, acute physiologic assessment and chronic health evaluation-II, bedside index for severity in acute pancreatitis, and multiple organ dysfunction syndrome scores); higher incidence of organ failure (acute kidney injury [AKI] and acute heart failure); worse prognosis (higher incidence of vasoactive and diuretic agent use, longer hospital stays, and higher hospital costs) compared to that of patients without anemia (all P < .05). After adjusting for potential confounders, acute physiologic assessment and chronic health evaluation-II, bedside index for severity in acute pancreatitis, multiple organ dysfunction syndrome scores, hospital stay, and hospital costs in anemic patients were higher than those in non-anemic patients; besides, the incidence of AKI and using a diuretic agent in anemic patients was 6.645 and 4.053 times that of non-anemic patients in AP, respectively (all P < .05). Acute pancreatitis patients with anemia have more disease severity, higher incidence of AKI, and worse prognosis compared to those without anemia.
贫血是许多疾病预后不良的危险因素。本研究旨在探讨贫血与急性胰腺炎(AP)严重程度和预后的关系。纳入 2016 年 7 月 1 日至 2020 年 12 月 31 日在广东药科大学第一附属医院住院的以急性胰腺炎为主要诊断的患者。随后,比较贫血组和非贫血组患者的疾病严重程度、并发症发生率和预后。共纳入 282 例急性胰腺炎患者,其中 68.43%的患者同时诊断为贫血。值得注意的是,这些患者的疾病更严重(更高的 RANSON、急性生理和慢性健康评估 II、床边急性胰腺炎严重程度指数和多器官功能障碍综合征评分);器官衰竭发生率更高(急性肾损伤[AKI]和急性心力衰竭);预后更差(血管活性和利尿剂使用的发生率更高、住院时间更长、住院费用更高)与非贫血患者相比(均 P<0.05)。调整潜在混杂因素后,贫血患者的急性生理和慢性健康评估 II、床边急性胰腺炎严重程度指数、多器官功能障碍综合征评分、住院时间和住院费用均高于非贫血患者;此外,贫血患者 AKI 和使用利尿剂的发生率分别是非贫血患者的 6.645 倍和 4.053 倍(均 P<0.05)。与非贫血患者相比,贫血的急性胰腺炎患者疾病严重程度更高、AKI 发生率更高、预后更差。